NT5E and precursor B-cell acute lymphoblastic leukemia: We observed a difference in the expression of CD39 and CD73 ectonucleotidases and an alteration in AMP and ADO metabolites; Therefore, we can suggest that a function rearrangement may be taking place in the canonical ADO production pathway of the purinergic system in B-ALL.